Cash Flow Pacira Biosciences, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
16.00
-63.00
61.00
13.00
56.00
20.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-38.00
-18.00
-45.00
-16.00
-25.00
-33.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
151.00
189.00
154.00
145.00
125.00
77.00
Cash Flow from Investing Activities
99.00
-83.00
77.00
-225.00
-20.00
-277.00
Cash Flow from Financing Activities
-369.00
17.00
-183.00
-401.00
380.00
222.00
Net Cash Inflow / Outflow
-118.00
123.00
49.00
-481.00
485.00
21.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Pacira Biosciences, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
16.874
82.6680000001666
-66.00
-79.59%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-38.266
28.1000000000566
-66.00
-236.18%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
151.994
132.388000000267
19.00
14.81%
Cash Flow from Investing Activities
99.481
84.34300000017
15.00
17.95%
Cash Flow from Financing Activities
-369.627
0
-369.00
0.00%
Net Cash Inflow / Outflow
-118.229
216.248000000436
-334.00
-154.67%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.077
-0.483000000000974
0.00
84.06%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -19.75% vs 22.46% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
151.99
189.39
-19.75%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
